(Q35614963)

English

Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.

scientific article published on July 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75. (English)

1 reference

Europe PubMed Central

9 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

object named as

A V Schally

1 reference

Europe PubMed Central

9 August 2017

author name string

T Yano

1

1 reference

Europe PubMed Central

9 August 2017

J Pinski

2

1 reference

Europe PubMed Central

9 August 2017

G Halmos

3

1 reference

Europe PubMed Central

9 August 2017

K Szepeshazi

4

1 reference

Europe PubMed Central

9 August 2017

K Groot

5

1 reference

Europe PubMed Central

9 August 2017

language of work or name

0 references

publication date

1 July 1994

1 reference

Europe PubMed Central

9 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

9 August 2017

91

1 reference

Europe PubMed Central

9 August 2017

7090-7094

1 reference

Europe PubMed Central

9 August 2017

15

1 reference

Europe PubMed Central

9 August 2017

Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Therapy of advanced ovarian cancer with D-Trp-6-LH-RH (decapeptyl) microcapsules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Determination of subcutaneous tumor size in athymic (nude) mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Treatment of advanced refractory ovarian carcinoma with a gonadotropin-releasing hormone analogue.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Improved silver technique for showing nucleolar organiser regions in paraffin wax sections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Lupron retards proliferation of ovarian epithelial tumor cells cultured in serum-free medium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Endocrine Factors in Common Epithelial Ovarian Cancer*

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Decrease in the AgNOR number in Dunning R3327 prostate cancers after treatment with an agonist and antagonist of luteinizing hormone-releasing hormone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Cancer statistics, 1992

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

27 July 2018

Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

25 September 2018

Estrogen and anti-estrogen effects on the growth of human epithelial ovarian cancer in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

25 September 2018

New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

25 September 2018

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=44344

25 September 2018

The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced ovarian carcinoma: response to the agonist D-Trp-6-LHRH

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gonadotropin-Releasing Hormone (GnRH)-Binding Sites in Human Breast Cancer Cell Lines and Inhibitory Effects of GnRH Antagonists*

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Some observations on the effect of a GnRH analog in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptors for D-Trp6-luteinizing hormone-releasing hormone, somatostatin, and insulin-like growth factor I in MXT mouse mammary carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine characterization of a human ovarian carcinoma (BG-1) established in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of radioimmunoassay for a potent luteinizing hormone-releasing hormone antagonist. Evaluation of serum levels after injection of [Ac-3-(2-naphthyl)-D-Ala1, D-Phe(pCl)2, 3-(3-pyridyl)-D-Ala3, D-Cit6, D-Ala10] LHRH

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A long-acting gonadotropin-releasing hormone agonist inhibits the growth of a human ovarian epithelial carcinoma (BG-1) heterotransplanted in the nude mouse

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/7518926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.91.15.7090

1 reference

Europe PubMed Central

9 August 2017

1994PNAS...91.7090Y

0 references

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35614963&oldid=1549821008"